Some users swear by it, but what science is behind the practice?
It's likely to follow the compounds that fast track through the clinical psychedelic renaissance.
The relationship between efficacy and potency is a key concept in understanding psychedelic drug pharmacology.
Some scientists are skeptical of the entourage effect in psychedelics as research companies are charging ahead with the concept.
MindMed just started a Phase 1 trial which is studying the effects of LSD + MDMA administered together.
“We have some [compounds] now that are unlike anything you’ve ever seen before.”
Exploring the historical, traditional, and entheogenic contexts of ayahuasca for further understanding of its therapeutic value.
Patent filings indicate that CaaMTech was the first company to propose an entourage effect in psychedelic compounds.
Research suggests that DMT may not be the only compound responsible for ayahuasca's effects.
This company is approaching psychedelic mushroom research literally from the ground up.